Catheter Precision Inc Quick Ratio (VTAK) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Catheter Precision Inc   (NYSEAMER: VTAK)

Catheter Precision Inc 's Quick Ratio

VTAK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Catheter Precision Inc 's Cash & cash equivalent grew by 317.01 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Catheter Precision Inc 's Quick Ratio to 0.16, Quick Ratio remained below Catheter Precision Inc average.

Within Medical Equipment & Supplies industry 171 other companies have achieved higher Quick Ratio than Catheter Precision Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3357, from total ranking in the first quarter 2026 at 3814.

Explain Quick Ratio?
How much Cash & cash equivalents VTAK´s has?
What are VTAK´s Current Liabilities?




VTAK Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 140.54 % 382.71 % 87.39 % 105.92 % 39.9 %
Y / Y Cash & cash equivalent Change 7.42 % -2 % -96.94 % 62.15 % 10600 %
Quick Ratio MRQ 0.16 0.02 0.02 0.39 0.37
VTAK's Total Ranking # 3357 # 3814 # 4289 # 1869 # 2072
Seq. Current Liabilities Change -43.43 % 405.2 % -26.63 % 14.71 % 13.52 %
Seq. Cash & cash equivalent Change 317.01 % 401.14 % -95.72 % 20.09 % 280.44 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 172
Healthcare Sector # 820
Overall Market # 3357


Quick Ratio Statistics
High Average Low
10.84 3.16 0
(Mar 31 2019)   (Jun 30 2024)




Financial Statements
Catheter Precision Inc 's Current Liabilities $ 11 Millions Visit VTAK's Balance sheet
Catheter Precision Inc 's Cash & cash equivalent $ 2 Millions Visit VTAK's Balance sheet
Source of VTAK's Sales Visit VTAK's Sales by Geography


Cumulative Catheter Precision Inc 's Quick Ratio

VTAK's Quick Ratio for the trailling 12 Months

VTAK Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 199.48 % 178.29 % 73.74 % 50.48 % 31.71 %
Y / Y Cash & cash equivalent TTM Growth -29.81 % -6.73 % -23.76 % 11.85 % -40.82 %
Quick Ratio TTM 0.11 0.13 0.24 0.44 0.47
Total Ranking TTM # 4135 # 3196 # 3151 # 2546 # 2521
Seq. Current Liabilities TTM Growth 19.41 % 87.12 % 11.29 % 20.44 % 10.96 %
Seq. Cash & cash equivalent TTM Growth 2.96 % -0.21 % -39.28 % 12.5 % 36.81 %


On the trailing twelve months basis Due to cut in Current Liabilities in the Q2 2026 to $11.17 millions, cumulative Quick Ratio decreased to 0.11 below the Catheter Precision Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Catheter Precision Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3196 to 4135.

Explain Quick Ratio?
How much Cash & cash equivalents VTAK´s has?
What are VTAK´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 914
Within the Market # 4135


trailing twelve months Quick Ratio Statistics
High Average Low
8.23 3.04 0.1
(Sep 30 2019)   (Jun 30 2026)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Novocure Limited  0.45 $ 99.287  Millions$ 220.710  Millions
Ss Innovations International Inc  0.43 $ 13.647  Millions$ 31.892  Millions
Stereotaxis Inc   0.42 $ 11.218  Millions$ 26.797  Millions
Glucotrack Inc   0.38 $ 1.124  Millions$ 2.988  Millions
Steris Plc  0.38 $ 482.300  Millions$ 1,283.300  Millions
Lakeland Industries Inc   0.37 $ 17.100  Millions$ 45.876  Millions
Femasys Inc   0.37 $ 1.444  Millions$ 3.887  Millions
Docgo Inc   0.37 $ 26.569  Millions$ 72.334  Millions
Sanuwave Health Inc   0.36 $ 9.376  Millions$ 25.723  Millions
Iridex Corp  0.36 $ 4.680  Millions$ 13.173  Millions
Heartsciences Inc   0.34 $ 1.657  Millions$ 4.861  Millions
Cadre Holdings inc   0.29 $ 53.984  Millions$ 187.734  Millions
Cytosorbents Corporation  0.24 $ 4.413  Millions$ 18.320  Millions
U S Physical Therapy Inc  0.23 $ 24.887  Millions$ 109.909  Millions
Accuray Incorporated  0.21 $ 40.623  Millions$ 191.405  Millions
Cerus Corporation  0.21 $ 17.980  Millions$ 85.790  Millions
Tenon Medical Inc   0.20 $ 1.677  Millions$ 8.305  Millions
Bioventus Inc   0.19 $ 29.457  Millions$ 154.471  Millions
Avita Medical Inc   0.19 $ 13.096  Millions$ 68.714  Millions
Bausch and Lomb Corp  0.19 $ 367.000  Millions$ 1,942.000  Millions
Dentsply Sirona Inc   0.18 $ 239.000  Millions$ 1,319.000  Millions
Adm Tronics Unlimited Inc   0.18 $ 0.223  Millions$ 1.235  Millions
Catheter Precision Inc   0.16 $ 1.839  Millions$ 11.166  Millions
Zimmer Biomet Holdings Inc   0.14 $ 410.000  Millions$ 3,013.500  Millions
Nexgel Inc   0.12 $ 1.692  Millions$ 14.440  Millions
Ufp Technologies Inc   0.12 $ 9.045  Millions$ 78.304  Millions
Solventum Corporation  0.11 $ 403.000  Millions$ 3,663.000  Millions
Nakamoto Inc   0.11 $ 19.072  Millions$ 179.474  Millions
Petvivo Holdings Inc   0.10 $ 0.135  Millions$ 1.313  Millions
The Pennant Group Inc   0.10 $ 15.273  Millions$ 152.406  Millions

Date modified: 2026-09-12T06:23:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.